PTC Therapeutics
PTCT
#3135
Rank
HK$39.26 B
Marketcap
HK$470.42
Share price
-6.97%
Change (1 day)
-11.38%
Change (1 year)

Market capitalization of PTC Therapeutics (PTCT)

Market cap: HK$39.26 Billion

As of November 2026 PTC Therapeutics has a market cap of HK$39.26 Billion. This makes PTC Therapeutics the world's 3135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PTC Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$39.26 B-20%
2025HK$49.07 B81.21%
2024HK$27.08 B66.73%
2023HK$16.24 B-25.37%
2022HK$21.76 B-0.88%
2021HK$21.95 B-31.99%
2020HK$32.28 B39.35%
2019HK$23.16 B70.34%
2018HK$13.60 B151.54%
2017HK$5.40 B86.23%
2016HK$2.90 B-65.91%
2015HK$8.51 B-35.53%
2014HK$13.21 B321.75%
2013HK$3.13 B

End of Day market cap according to different sources

On Oct 31st, 2026 the market cap of PTC Therapeutics was reported to be:

HK$39.26 Billion
by Nasdaq info icon info icon
HK$39.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
HK$2.382 T 5,967.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$1.110 T 2,728.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$17.39 B-55.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$15.42 B-60.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.95 B-95.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$88.24 B 124.75%๐Ÿ‡บ๐Ÿ‡ธ USA